Siemens posts Q2 profit, halts heart surgery robots

U.S.-German Siemens Healthineers announced on Wednesday it is halting its heart surgery robot business after a 30 percent drop in Q2 profits.

Chief Financial Officer Jochen Schmitz said the “use of Corindus robots for cardiology operations did not fulfil our expectations.”

Revenues decreased by 2.5 percent at the second quarter, making €5.35 billion. Profits of the firm’s Diagnostics (Dx) unit is expected to decline by 23 percent-26 percent.

“The decline can be traced to a decrease in demand for COVID antigen tests falls. David Adlington, J.P. Morgan analyst explained “diagnostics continued to be the key disappointment.”